| 标题 |
Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:Manali Kamdar; Scott R. Solomon; Jon Arnason; Patrick B. Johnston; Bertram Glaß; et al 出版日期:2022-06-01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)